1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. MANNKIND CORP
Mannkind Corp XNAS: MNKD

Mannkind Corp Live Stock Price Today, Share Analysis and Chart

about

MannKind Corp is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. Its approved product, Afrezza (insulin huma...

Read More
3.87 0.05 (1.31%)
49.28% Fall from 52W High
2.5M
XNAS Volume

XNAS 30 Jul, 2025 5:30 PM (EDT)

Watchlist

Portfolio

Alert

Share
Board Meeting
The next board meeting for Mannkind Corp is on 07 Aug 2025 for the purpose of MannKind Corp Second Quarter Earnings Results for 2025 See details
Durability score
Not Eligible
-
Valuation Score
Expensive Valuation
23.5 / 100
Momentum Score
Technically Neutral
44.5 / 100
Analyst Price Target
9
1Yr Price target upside is 136%
8 analysts

9

S

5

W

5

O

0

T

SWOT Analysis

Mannkind Corp Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..